Wen Zhou

6PUBLICATIONS
1CO-AUTHORS
Biologically active moleculesNeurology and neuromuscular diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 18, 2024
Hypoxia Activated Nitric Oxide Donor Compounds for the Prevention and Treatment of Myocardial Hypoxia-Induced Injury.

Wanxiang Yang, Wen Zhou, Shaohua Gou

|Sep 10, 2024
A Lysosome-Targeting hNEU1 Inhibitor Treats Myocardial Infarction: A Potential Therapeutic Breakthrough.

Wen Zhou, Wanxiang Yang, Ping Jiang

|Nov 16, 2023
Discovery of Efficient Hypoxia-Targeted NO Donor Compounds to Alleviate Hypoxia Cardiac Disease.

Wanxiang Yang, Wen Zhou, Shaohua Gou

|Sep 28, 2022
Hypoxia-Activated Prodrugs with Dual COX-2/CA Inhibitory Effects on Attenuating Cardiac Inflammation under Hypoxia.

Wen Zhou, Chunping Wang, Zhikun Liu

|Apr 12, 2021
An Original Aspirin-Containing Carbonic Anhydrase 9 Inhibitor Overcomes Hypoxia-Induced Drug Resistance to Enhance the Efficacy of Myocardial Protection.

Wen Zhou, Bin Zhang, Keyu Fan

|Jan 12, 2019
A mitochondrion-targeting tanshinone IIA derivative attenuates myocardial hypoxia reoxygenation injury through a SDH-dependent antioxidant mechanism.

Yun-Peng Zhao, Fei Wang, Wei Jiang

Pageof 1

Frequent Collaborators

4 joint publications

Shaohua Gou